NCT00108433 - Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

September 30, 2006

Conditions

BacteremiaGram-Positive Bacterial Infections

Interventions

DRUG

Cefazolin IV

DRUG

Linezolid IV

DRUG

Vancomycin (IV)

Trial Locations (17)

0

Pfizer Investigational Site, Bogota

18100

Pfizer Investigational Site, Imperia

21201

Pfizer Investigational Site, Baltimore

21230

Pfizer Investigational Site, Baltimore

64239

Pfizer Investigational Site, Tel Aviv

21201-1524

Pfizer Investigational Site, Baltimore

Unknown

Pfizer Investigational Site, Barranquilla

Pfizer Investigational Site, Bogotá

500 082

Pfizer Investigational Site, Hyderbad

560 034

Pfizer Investigational Site, Bangalore

560 054

Pfizer Investigational Site, Bangalore

110 044

Pfizer Investigational Site, New Delhi

160 012

Pfizer Investigational Site, Chandigarh

600 004

Pfizer Investigational Site, Chennai

42-200

Pfizer Investigational Site, Częstochowa

975 17

Pfizer Investigational Site, Banská Bystrica

950 01

Pfizer Investigational Site, Nitra